LKtime Biotech
Latest round
- Series B
Last raised
- Jul 2024
Total raised
- $26M
Investors
- 3
About LKtime Biotech
Based in Zhongshan, China, and founded in 2021, LKtime Biotech is a CDMO service provider for biological products, committed to providing users with relevant biotechnology products and services. The company has set up a research and development center and two production centers. LKtime Biotech focuses on providing macromolecular CDMO (Contract Development and Manufacturing Organization) services from DNA to IND (Investigational New Drug) or BLA (Biologics Licence Application) for innovative biopharmaceutical companies. The company has mammalian cell (such as CHO and 293 cell) platforms and microbial (such as yeast, E. coli) platforms.) The company generates revenue by providing macromolecular CDMO services. The company will further expand its commercial production base, upgrade its innovative R&D center and pilot base, and expand its production capacity.
Who invested in LKtime Biotech
3 investors across 1 round
See all investors in LKtime Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 2, 2024
Amount
$26M
Investors
Questions about LKtime Biotech
Who invested in LKtime Biotech?
LKtime Biotech has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LKtime Biotech raised?
LKtime Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did LKtime Biotech last raise money?
LKtime Biotech's most recent round on record is a Series B, in Jul 2024.
What does LKtime Biotech do?
Based in Zhongshan, China, and founded in 2021, LKtime Biotech is a CDMO service provider for biological products, committed to providing users with relevant biotechnology products and services.
Where is LKtime Biotech headquartered?
LKtime Biotech is headquartered in Zhongshan, China.
Which VCs invest in companies like LKtime Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at LKtime Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like LKtime Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.